Cases & Deals

Maverick Capital affiliates participate in Series C financing round by Spiracur

Clients Maverick Capital Ltd.

Jones Day advised affiliates of Maverick Capital Ltd. in connection with their purchase of Series C Preferred Stock in a private placement by Spiracur, Inc., a medical device company focused on the development of innovative wound healing technologies. Co-investors include De Novo Ventures, Kleiner Perkins Caufield & Byers, New Leaf Venture Partners, and Pinnacle Ventures, L.L.C.